Five entities – four companies and one executive – are now being probed by the Competition Commission of India after complaints of anticompetitive stockiest-ship appointments. Pharmaceutical companies Cipla, Macleods Pharmaceutical and FDC Ltd are all under investigation, as well as the trade body Himachal Pradesh Society of Chemist and Druggist Alliance, as well as its president. According to reports, the CCI is looking into allegations that the trade body illegally controlled the appointment of stockist-ship of the pharmaceutical companies that are part of the Society. The CCI has recognized the complaints that competitors could not be granted stockish-ship due to the collusive agreements.
Full Content: Money Life
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Justice Department Moves to End NCAA Transfer Rule
May 30, 2024 by
CPI
Kenya’s Competition Authority Proposes Tougher Regulations on Big Tech
May 30, 2024 by
CPI
KKR Secures EU Antitrust Approval for $24 Billion Acquisition of Telecom Italia’s Fixed-Line Network
May 30, 2024 by
CPI
European Court Sides with Tech Giants in Italian Regulatory Dispute
May 30, 2024 by
CPI
US Steel and Nippon Steel Secure International Approvals for $14.9B Merger
May 30, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Merger Guidelines Retrospective
May 21, 2024 by
CPI
Mergers of Complements
May 21, 2024 by
CPI
Personality Traits, Private Equity, and Merger Analysis
May 21, 2024 by
CPI
The 2023 Merger Guidelines: Lessons in the Importance of Incipiency, Modern Economics, and Monopsony
May 21, 2024 by
CPI
The 2023 Merger Guidelines: Sharpening Merger Analysis
May 21, 2024 by
CPI